Candidiasis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

The global candidiasis market is primarily driven by an increase in candidiasis instances worldwide, as well as a high rate of candidiasis diagnosis and treatment. However, antifungal medication adverse effects, product recalls, and severe regulatory requirements are expected to stifle the worldwide candidiasis treatment market's expansion in the near future. Nonetheless, the global candidiasis treatment market is expected to benefit from increased research and development spending by major players, strategic collaborations between firms, and a robust product pipeline throughout the forecast period.

The global candidiasis market may be divided into four categories: candidiasis, administration route, distribution channel, and geography. The global candidiasis treatment market is divided into three categories: vaginal candidiasis, invasive candidiasis, and esophageal candidiasis. The global candidiasis treatment market can be divided into three categories based on the route of administration: oral, parenteral, and topical. The global candidiasis market can be divided into three categories: hospital pharmacies, retail pharmacies and medicine shops, and online sales.

The global candidiasis market can be divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa based on geography. Invasive candidiasis is a prevalent kind of health-care-associated infection, according to the CDC. Invasive candidiasis is expected to affect around 50,000 people in the United States each year. Candidemia, the most common form of invasive candidiasis, affects 10 to 14 people per 100,000 in the United States each year. Due to a large number of cases of candidiasis, a high rate of candidiasis diagnosis and treatment, and a strong health care infrastructure in the region, the candidiasis treatment market in North America held a major market share in 2017.

Invasive candidiasis was found in nearly 5 people per 100,000 in the United Kingdom, according to a study published in the Journal of Fungi in 2017. Invasive candidiasis is expected to affect almost 6 to 7 instances per 100,000 people in Spain each year, but it is more common in Eastern Europe.